Eupraxia Pharmaceuticals Inc (EPRX.TO) saw a slight uptick in its stock price amidst a week of modest fluctuations.
This week, Eupraxia Pharmaceuticals Inc's stock price experienced a 1.80% increase on Wednesday, following a slight decline of 1.82% over the past week. The company's recent news and market movements indicate a cautious but optimistic outlook as it continues to develop its pharmaceutical offerings.
Investor takeaway: Eupraxia's recent transfer to the Nasdaq Global Select Market may enhance its visibility and investor interest, despite the lack of recent major news. Investors should monitor upcoming developments closely.
Advertisement
Eupraxia Pharmaceuticals Inc
EPRX.TO
EPRX.TO
Eupraxia Pharmaceuticals Inc
WealthAwesomeMarket cap
$769.75M
52W high
$12.86
52W low
$7.35
1W change
-1.82%
Beta
1.49
Analyst Price Targets
Based on analyst covering EPRX · as of Sep 28, 2026
Wall Street analysts forecast EPRX stock price to rise 37.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$16.33
+37.7% Upside
Previously C$16.00 on Sep 17, 2026
Current Price
C$11.86
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EPRX's historical volatility
30-Day Vol
76.9%
Annualized
90-Day Vol
62.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$14.18
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$12.59 | C$9.65 – C$16.41 |
| 60 trading days | C$13.36 | C$9.18 – C$19.44 |
| 90 trading days | C$14.18 | C$8.96 – C$22.45 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Eupraxia Pharmaceuticals Inc Stock Performance Highlights
The stock has demonstrated a 27.80% increase over the past month, indicating a positive trend despite recent volatility.
Bull case
Eupraxia’s successful transfer to the Nasdaq could attract more institutional investors, which might lead to increased stock liquidity and a rise in value over time.
Bear case
Ongoing losses, reflected in a negative return on equity and a profit margin of 0.0%, could raise concerns about the company’s financial health and long-term viability.
Recent Price Action
Advertisement
Eupraxia Pharmaceuticals Inc (EPRX.TO) closed at C$11.86 on Wednesday, marking a 1.80% increase for the day. However, the stock has seen a slight decline of 1.82% over the past week, despite a significant rise of 27.80% in the last month and a year-to-date increase of 13.38%.
Company News and Developments
No major news has been reported this week for Eupraxia Pharmaceuticals. However, the company recently completed its transfer to the Nasdaq Global Select Market, which is expected to enhance its visibility and accessibility to a broader range of investors. This strategic move could potentially lead to increased trading activity and interest in the stock.
Technical Picture
From a technical standpoint, Eupraxia's stock is currently trading above both its 50-day moving average of C$10.01 and its 200-day moving average of C$10.12, indicating a bullish trend. The stock's 52-week range stands at C$7.35 to C$12.86, suggesting it is currently trading at around 82% of its range. The stock's beta of 1.49 indicates it is more volatile than the overall market, which may appeal to risk-tolerant investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
